Presentation Topic : Vaccination Deployment in Protection against Influenza A (H1N1) Infection PhD Student : Shang XIA Supervisor : Prof. Jiming LIU Department.

Slides:

Advertisements

Similar presentations

The Disease Dynamics research group at the Department of Applied Mathematics and Theoretical Physics (DAMTP) at the University of Cambridge is headed by.

Advertisements

What is Epidemiology? (1)

Modelling as a tool for planning vaccination policies

How can Modeling Help in Emerging Epidemics? John Grefenstette, PhD Public Health Dynamics Lab Health Policy & Management Pitt Public Health Dec 5, 2014.

Challenges of the 2009 H1N1 Pandemic Influenza: Charles Penn Global Influenza Programme World Health Organization Geneva.

Population Health for Health Professionals. Module 2 Epidemiology The Basic Science of Public Health.

Presentation Topic : Modeling Human Vaccinating Behaviors On a Disease Diffusion Network PhD Student : Shang XIA Supervisor : Prof. Jiming LIU Department.

Health Aspect of Disaster Risk Assessment Dr AA Abubakar Department of Community Medicine Ahmadu Bello University Zaria Nigeria.

1 Avian Influenza Rapid Response Team Training. 2 What is a Rapid Response Team? A team of professionals that investigates suspected cases of avian influenza.

1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.

Preventing Smallpox Epidemics Using a Computational Model By Chintan Hossain and Hiren Patel.

The role of cross-immunity and vaccines on the survival of less fit flu-strains Miriam Nuño Harvard School of Public Health Gerardo Chowell Los Alamos.

1 The epidemic in a closed population Department of Mathematical Sciences The University of Liverpool U.K. Roger G. Bowers.

Modeling the SARS epidemic in Hong Kong Dr. Liu Hongjie, Prof. Wong Tze Wai Department of Community & Family Medicine The Chinese University of Hong Kong.

Internet Quarantine: Requirements for Containing Self-Propagating Code David Moore et. al. University of California, San Diego.

Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.

Comparison of Private vs. Public Interventions for Controlling Influenza Epidemics Joint work with Chris Barrett, Jiangzhuo Chen, Stephen Eubank, Bryan.

The Disease Dynamics research group in the Department of Applied Mathematics and Theoretical Physics (DAMTP) in the University ofDAMTP Cambridge is headed.

How does mass immunisation affect disease incidence? Niels G Becker (with help from Peter Caley ) National Centre for Epidemiology and Population Health.

Infectious Disease Epidemiology Sharyn Orton, Ph.D. American Red Cross, Rockville, MD Suggested reading: Modern Infectious Disease Epidemiology (1994)

Methods to Study and Control Diseases in Wild Populations Steve Bellan, MPH Department of Environmental Sci, Pol & Mgmt University of California at Berkeley.

Infectious disease, heterogeneous populations and public healthcare: the role of simple models SIAM CSE 2009 K.A. Jane White Centre for Mathematical Biology.

Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.

Stanislaus County It’s Not Flu as Usual It’s Not Flu as Usual Pandemic Influenza Preparedness Renee Cartier Emergency Preparedness Manager Health Services.

Best Practice Guideline for the Workplace During Pandemic Influenza Occupational Health and Safety Employment Standards.

Public Health in Tropics :Further understanding in infectious disease epidemiology Taro Yamamoto Department of International Health Institute of Tropical.

SIR Epidemic Models CS 390/590 Fall 2009

Lessons from the European Experience with A(H1N1) 2009 Angus Nicoll CBE European Centre for Disease Prevention and Control 3 rd meeting of the National.

Comparing Effectiveness of Top- Down and Bottom-Up Strategies in Containing Influenza Achla Marathe, Bryan Lewis, Christopher Barrett, Jiangzhuo Chen,

KEY CONCEPT Some viral diseases can be prevented with vaccines.

CODE RED WORM PROPAGATION MODELING AND ANALYSIS Cliff Changchun Zou, Weibo Gong, Don Towsley.

Modelling infectious diseases Jean-François Boivin 25 October

The Impact of Epidemiology in Public Health Robert Hirokawa Epidemiologist, Science and Research Group HHI / TSP, Hawaii Department of Health.

Epidemiology With Respect to the Dynamics of Infectious Diseases Huaizhi Chen.

Case study: infectious disease Professor Anne Johnson FMedSci Head, Department of Primary Care and Population Sciences, Royal Free and University College.

Measles Vaccination in Epidemic Contexts RF Grais, ACK Conlan, MJ Ferrari, C Dubray, A Djibo, F Fermon, M-E Burny, KP Alberti, I Jeanne, BS Hersh, PJ Guerin,

EpiFast: A Fast Algorithm for Large Scale Realistic Epidemic Simulations on Distributed Memory Systems Keith R. Bisset, Jiangzhuo Chen, Xizhou Feng, V.S.

PRE-PANDEMIC VACCINATION MAY HALT THE SPREAD OF A PANDEMIC MATHEMATIC MODELING.

US Situation Update and CDC International Response H1N1 Pandemic US Situation Update and CDC International Response Peter Nsubuga, MD, MPH On behalf of.

New vaccines mean new strategies: A theoretical exploration of the impact of HPV/HSV vaccines. Geoff Garnett Department of Infectious Disease Epidemiology,

Mitigating the Impact of Pandemic (H1N1): Options for Public Health Measures Dr Li Ailan Communicable Disease Surveillance & Response (CSR) WHO Western.

Avian Influenza When avian influenza hits will science have an efficient vaccine?

Showcase /06/2005 Towards Computational Epidemiology Using Stochastic Cellular Automata in Modeling Spread of Diseases Sangeeta Venkatachalam, Armin.

The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.

H1N1 Flu Update Jason Eberhart-Phillips, MD, MPH Director of Health and Kansas State Health Officer CHAC Immunization Advisory Committee February 19, 2010.

Karaganda State Medical University Epidemiology as a science. Subject, tasks and methods of epidemiology Lecture: Kamarova A.M.

Coevolution of Epidemics, Social Networks, and Individual Behavior: A Case Study Joint work with Achla Marathe, and Madhav Marathe Jiangzhuo Chen Network.

The Impact of Epidemiology in Public Health Robert Hirokawa, DrPH Epidemiologist, Science and Research Group HHI / TSP, Hawaii Department of Health.

SIR Epidemic and Vaccination

FDA’s Role in Facilitating the Availability of Influenza Vaccine Norman W. Baylor, Ph.D. Director, Office of Vaccines Research and Review CBER/FDA.

Advisor: Professor Sabounchi

The Vermont Department of Health Update on Pandemic Threat Cort Lohff, MD, MPH State Epidemiologist Guidance Support Prevention Protection.

What Is H1N1 (Swine Flu) Pandemic Influenza? Colorized image of H1N1 from a transmission electron micrograph. Source: CDC.

Comparison of Individual Behavioral Interventions and Public Mitigation Strategies for Containing Influenza Epidemic Joint work with Chris Barrett, Stephen.

Dynamic Simulation of an Influenza Pandemic: Planning Aid for Public Health Decision Makers M. Eichner 1, M. Schwehm 1, S.O. Brockmann 2 1 Department of.

Epidemiology of Swine Influenza H1N1 Amman 5/5/2009 Dr. Labib Sharif Associate Prof. Of Epidemiology Faculty of Veterinary Medicine Jordan University of.

Avian Influenza - The Human Health Perspective Dr. Andrew Larder FRCPC.

Biological Attack Model (BAM) Progress Report March 8 Sponsor: Dr. Yifan Liu Richard Bornhorst Robert Grillo Deepak Janardhanan Shubh Krishna Kathryn Poole.

Mathematical modelling of male circumcision in sub-Saharan Africa predicts significant reduction in HIV prevalence Greg Londish 1, John Murray 1,2 1 School.

Internet Quarantine: Requirements for Containing Self-Propagating Code

Sangeeta Venkatachalam, Armin R. Mikler

Network Science in NDSSL at Virginia Tech

KEY CONCEPT Some viral diseases can be prevented with vaccines.

Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases An Vandebosch, PhD Joint Statistical meetings,

What is the pattern of risk from a global pandemic

Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 Phase 6 Cutaneous Inhalation

Susceptible, Infected, Recovered: the SIR Model of an Epidemic

Finnian Hanrahan Infectious diseases and public health

KEY CONCEPT Some viral diseases can be prevented with vaccines.

Presentation transcript:

Presentation Topic : Vaccination Deployment in Protection against Influenza A (H1N1) Infection PhD Student : Shang XIA Supervisor : Prof. Jiming LIU Department of Computer Science March 15, th Postgraduate Research Symposium Co-supervisor : Dr. William Kwok-Wai

Content: 1 2 Research Motivation & Objectives Epidemic Infection Dynamics 3 Vaccine Deployment Factors 4 SIV model and Vaccination Simulation Page 1/17 5 Conclusion

 Vaccination Dynamics  Disease Diffusion Dynamics Global Dynamics  Social Contact Network  Entities Infection Model  Decision Making Local Behaviors Global Epidemic Spreading Dynamics Previous Work : Page 2/17

 Epidemic Spreading  Epidemic Interventions Background : Virus Infection : Individuals’ pathological infection. Virus Transmission : Individuals’ contact relationship. Vaccine Immunization : Individual immunized from virus infection. Contact Limitations : Population’s contact landscape reconstructed. Page 3/17

 Simulation Model of Infection Dynamics  Evaluation of Vaccination Deployment Research Concerns : Pathological Infection : Heterogeneity of individual’s infection vulnerability. Contact Transmission : Heterogeneity of Individuals’ contact frequency. Vaccine Availability :  Total amount of vaccine doses.  Starting time of vaccine releasing. Vaccine Distribution : Vaccination priority of each population group. Page 4/17

 Model of Simulating Virus Infection Dynamics Virus Infection Model : Infection Status Label  Three status labels: Susceptible (S), Infected (I), Vaccinated (V). Host Population Structure :  Population are divided into 6 Age Groups. Heterogeneity of Vulnerability  Differentiation of Infection Rate and Recovery Rate for individual in each age group. Heterogeneity of Transmissibility : Contact Frequency within and cross each Age Groups. S-I-V Model Page 5/17

Virus Infection Model (Con.) (Ref. 1) (Ref. 2) (Ref.3) Page 6/17

 Factors in Vaccination Deployment Plan Vaccination Deployment : Vaccine Availability  Total Amount of Vaccine The proportion of vaccinated population of the host.  Releasing Time The time of first batch of vaccine being released. Vaccine Distribution  Vaccination Priority for each age groups.  Vaccination by Vulnerability.  Vaccination by Transmissibility. Page 7/17

Vaccination Deployment (Con.) 1. The amount of total vaccine doses: Low Quantity5 million8% Middle Quantity10 million16% Ample Quantity20 million32% 2. Vaccine Releasing Time: Pre-epidemic spreadingT = 0 day Incipient Infection StageT = 50 day Infection Mass Spreading StageT = 100 day Infection Stable StageT = 150 day  Settings of Vaccination Deployment 3. Vaccine Distribution Priority Vaccination by VulnerabilityGroup 1(0-4) & Group 6 (65+) Vaccination by TransmissibilityGroup 3 (15-24) & Group 4(25-44) Vaccination by RandomAll 6 Groups Page 8/17

Simulation of Infection Dynamics  Three Stages of Infection Dynamics without Vaccination Page 9/17

Simulation of Infection Dynamics Incipient Infection Stage  The total percentage of infections is relatively low.  The speed of newly increased infection is slow.  Infection Transmission is confined within initial groups. Infection Mass Spreading Stage  The number of newly increased infection are increased sharply.  The infection positive feedback through cross group contact. Infection Stable Stage  The total number of infection is high.  The increase of newly infection is stagnant.  The cross group infection keep at a high level. Page 10/17

Simulation of Vaccination Deployment  The impact of the Amount of Vaccine Page 11/17

Simulation of Vaccination Deployment  The impact of the Vaccine Releasing Page 12/17

Simulation of Vaccination Deployment  The impact of the Vaccine Distribution Page 13/17

Simulation of Vaccination Deployment  The Impact of three Vaccine Deployment Factors Total AmountReleasing TimeVaccine Distribution Increase vaccine amount Earlier Releasing TimeRandomlyTransmissibilityVulnerability Risk of Infectious Contact Lowered Lowered: T>R>V Risk of Successful Infection Lowered: V>R>T Tipping Point of Phase Transition Delayed Infection Rising Time Prolonged Prolonged: V>T>R Speed of Convergence to Stable Infection Slowed Slowed: V>T>R Stable Infection Percentage Decreased Decreased: V>T>R Page 14/17

 SIV Model  Evaluation of Vaccination Deployment Factors Conclusion : Pathological Infection : Heterogeneity of individual’s infection vulnerability. Contact Transmission : Heterogeneity of Individuals’ contact frequency. Vaccine Availability :  Total amount of vaccine doses.  Starting time of vaccine releasing. Vaccine Distribution : Vaccination priority of each population group. Page 15/17

1.C. Wroth and A. Wiles. Key population and vital statistics. Technical report, Office for National Statistics, J. Mossong, ect. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine, 5(3), March E. Miller, K. Hoschler, ect. Incidence of 2009 pandemic influenza a h1n1 infection in england: a cross-sectional serological study. The Lancet, Early Online Publication. Reference : Page 16/17

Q & A Thank You Very Much!